Matthew Stanton
Stock Analyst at Jefferies
(0.19)
# 4,151
Out of 4,840 analysts
5
Total ratings
33.33%
Success rate
-38.22%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $6.03 | +32.67% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $0.92 | +252.65% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $21.78 | +1.01% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $27.00 | +137.04% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $6.03
Upside: +32.67%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $0.92
Upside: +252.65%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $21.78
Upside: +1.01%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $27.00
Upside: +137.04%